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ASSESSING THE EFFECTS OF TREATMENT IN HIV-TB CO-INFECTION
MODEL
SACHIN KUMAR AND SHIKHA JAIN∗
Abstract. We propose a population model for HIV-TB co-infection dynamics by considering
treatments for HIV infection, active tuberculosis and co-infection. The HIV only and TB only
models are analyzed separately, as well as full model. The basic reproduction numbers for TB (RT0 )
and HIV (RH0 ) and overall reproduction number for the system R0 = max{R
T
0 ,R
H
0 } are computed.
The equilibria and their stability are studied. The main model undergoes supercritical transcritical
bifurcation at RT0 = 1 and R
H
0 = 1 whereas the parameters β
∗ = βe and λ∗ = λσ act as bifurcation
parameters, respectively. Numerical simulation claims the existence of interior equilibrium when
both the reproduction numbers are greater than unity. We explore the effect of early and late HIV
treatment on disease-induced deaths during the TB treatment course. Mathematical analysis of
our model shows that successful disease eradication requires treatment of single disease, that is,
treatment for HIV only and TB only infected individuals with addition to co-infection treatment
and in absence of which disease eradication is extremely difficult even for R0 < 1. When both the
diseases are epidemic, the treatment for TB only infected individuals is very effective in reducing
the total infected population and disease-induced deaths in comparison to the treatment for HIV
infected individuals while these are minimum when both the single disease treatments are given
with co-infection treatment.
1. Introduction
According to WHO, Tuberculosis is one of the top 10 causes of death worldwide [22, 25]. Tu-
berculosis (TB) is a bacterial disease which is primarily caused by the bacteria Mycobacterium
Tuberculosis and is usually acquired by inhaling TB bacteria from surrounding air. All the infected
people are not equally infectious and generally, it is only people with TB of the throat or lungs
who are infectious. The bacteria get released in air by a carrier with active TB through coughing,
sneezing or talking. Most infections do not have symptoms, in that case it is known as latent
tuberculosis and people with latent TB do not spread the disease. Inhaling only a few of these
germs are sufficient to get infected. About one quarter of the world’s population is infected with
TB [21], while most are in latent phase.
HIV, the Human Immunodeficiency Virus infects cells of immune system, destroying their func-
tion. HIV infects vital cells in the human immune system such as helper T cells (specifically CD4+
T cells), macrophages, and dendritic cells. As it hijacks the T cells that help keep the immune
system working, HIV is particularly devastating to immune health. In the process of replication,
the virus destroys increasing numbers of T cells. The T cells of an important part of the immune
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system are annihilated, leaving the body open to opportunistic infections. The immune system is
thus deteriorated and no longer fulfils its role of fighting infections and diseases. Acquired immun-
odeficiency syndrome (AIDS) is a term for the most advanced stages of HIV infection. HIV can be
transmitted through unprotected sexual intercourse, and oral sex with an infected person, trans-
fusion of contaminated blood and sharing of contaminated needles, syringes, surgical equipment
or other sharp instruments. It may also be transmitted between a mother and her infant during
pregnancy, childbirth and breastfeeding. In 2015, an estimated 44% of new infections occurred
among key populations and their partners [26].
TB is a leading killer of HIV-positive people: in 2015, 35% of HIV deaths were due to TB
[21]. Lowered immunity due to HIV infection increases the susceptibility to TB infection. People
infected with HIV are 20 to 30 times more likely to develop active TB disease than the uninfected
ones. TB is a treatable and curable disease but it is important to complete the entire course of
medications even after one feels well. Between 2000 to 2015, an estimated 49 million lives were
saved through TB diagnosis and treatment [21]. Though HIV infection has no permanent treatment,
ART (Antiretroviral Therapy) can slow down the progression of HIV in the body to near a halt.
ART reduces the risk of TB morbidity and mortality among people living with HIV. When ART
is combined with TB preventive therapy, it can have a significant impact on TB prevention. Since
TB can be cured effectively with treatment and complete treatment course being short, the usual
recommendation is to start it immediately. The DOTS strategy makes no distinction between
settings with different levels of HIV infection, yet outcomes will inevitably differ according to
the epidemiology of HIV infection [6]. Initiating ART soon after the beginning of TB treatment
increases the risk of IRIS (Immune Reconstruction Inflammatory Syndrome) which worsens TB
infection and causes severe medical complications, while its delay until completion of TB treatment
course increases the risk of death due to HIV. Therefore, it is difficult to identify the correct
initiation of ART with TB treatment.
The negative impact of synergic interactions between TB and HIV have caused worldwide con-
cern. Mathematical modelling of HIV, TB and HIV/TB co-infections have been reported by several
researchers. Guzzetta et. al [10] proposed an age-structured, socio-demographic individual based
model (IBM) with a realistic, time-evolving structure of preferential contacts in a population.
Trauer et. al [23] presented a mathematical model to simulate tuberculosis (TB) transmission in
highly endemic regions of the Asia-Pacific, where epidemiology does not appear to be primarily
driven by HIV-coinfection. Long et. al [13] proposed a co-epidemical model for HIV-TB infection
and presented an analysis in the population of India. Roeger et. al [17] proposed an 8 compart-
mental model of HIV-TB co-infection in which qualitative analysis of the model has been done.
They discussed the stability and disease prevalence in the model. Silva et. al [19] proposed a popu-
lation model for HIV-TB/AIDS co-infection transmission dynamics, which considers antiretroviral
therapy for HIV infection and treatments for latent and active tuberculosis. Bhunu et. al [1] devel-
oped a model that in-corporates all aspects of TB transmission dynamics as well as aspects of HIV
transmission dynamics to come with a distinct detailed co-infection model for HIV and TB. Naresh
et. al [15] developed a HIV/TB co-epidemic model assuming that AIDS cases are non- infectious
and did not include all stages of HIV and TB infection. Gakkhar and Chavda [9] formulated a
simple epidemic HIV-TB co-infection model. Kaur et. al [12] developed a deterministic non-linear
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HIV-TB co-infection model which discusses the role of screening and treatment in the transmis-
sion dynamics of HIV/AIDS and tuberculosis co-infection. Mallela et. al [14] developed an eight
compartmental model and studied the effect of HIV treatment in different phases of TB treatment.
Work done by Mallela et. al is the motivation for the present paper. In the present paper
necessity of single disease infection treatments that is treatment for TB only and HIV only patients
is also studied with the HIV treatment during different phases of TB treatment.
The paper is organised as follows: in Section 2, a twelve compartmental model for HIV-TB
co-infection and treatment has been developed and positivity and boundedness of the solutions is
proved. In Sections 3 and 4, TB and HIV sub-models are analyzed, respectively, and the respective
reproduction numbers are calculated. The existence and stability conditions of equilibria are also
deduced. In Section 5, the main model is discussed with its reproduction number and stability of
equilibria. In Section 6, numerical computations of the model are performed to explore the HIV-TB
co-infection dynamics. The effect of reproduction number on the infected population is studied.
The effect of early or late initiation of HIV treatment during TB treatment course and the necessity
of single disease infection treatment are discussed. We summarize our results with conclusion in
Section 7.
2. Model formulation and basic properties
The model subdivides the human population into twelve mutually-exclusive compartments,
namely susceptible individuals (S), TB-latently infected individuals (TL), TB-infected individu-
als who are infectious and have active TB (TI), TB-infected individuals who are under treatment
for TB (TT ), HIV infected individuals (H), HIV infected individuals co-infected with latent TB
(HL), HIV infected individuals under treatment for HIV infection (H
T ), co-infected Individuals
with active TB (C), co-infected individuals with active TB under early phase of treatment for TB
(C1), co-infected individuals with active TB under late phase of treatment for TB (C2), co-infected
individuals with active TB under early phase of TB treatment as well as going through ART (CT1 )
and co-infected individuals with active TB under late phase of TB treatment along with ART (CT2 ).
The total population at time t, denoted by N(t), is given by
N(t) =S(t) + TL(t) + TI(t) +H(t) +HL(t) +H
T (t) + C(t)
+ C1(t) + C2(t) + C
T
1 (t) + C
T
2 (t) + TT (t).
We assume that all individuals in a given compartment are identically infectious, which might
ignore potential effects caused due to variation among individuals. The susceptible cannot get
HIV and TB infection simultaneously that means there is no direct transmission from the class of
susceptible to the class of individuals co-infected with HIV and TB. The susceptible population
is increased by the constant recruitment rate Λ which is assumed to simplify the model. All
individuals in different compartments suffer from natural death rate d while dT and dH are disease
induced death rates due to TB and HIV separately. We ignore the temporal immunity to recover
from latent TB because nowdays modern lifestyle has lowered the immunity [2] and consider direct
and endogenous reinfection only. Early initiation of ART increases the probability of developing
IRIS. Since initiation of ART with TB treatment alters the disease induced death rate, therefore
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Figure 1. Schematic Diagram
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we consider it to be dTH and γ is the probability of developing IRIS during the early phase of co-
treatment for compartment CT1 and α =
γρ1
ρ1+ρ2
during late phase of co-treatment for compartment
CT2 [14]. Hence, the rate of IRIS development in C
T
2 compartment decreases as 1/ρ1 increases.
We assume σ and e are per capita contact rates for HIV and TB respectively. We assume β
to be the probability of TB infection per contact with a person with active TB and λ is the
probability of HIV infection per contact with a HIV infectious person. We assume that people
under treatment for any disease are not infectious for spreading that disease since they are aware
of their illness, so are precautious to the spread of disease. Secondly, treatment of TB reduces its
infectiousness rapidly [18]. In this model, we do not consider the treatment of latent TB and only
sexual transmission of HIV is considered. The force of infection λT associated with TB is given by
λT = βe
(TI + C)
N
. (2.1)
The force of infection λH associated with HIV is given by
λH = λσ
(H +HL +C + C1 + C2)
N
. (2.2)
We further assume that co-infected individuals under TB-treatment die of HIV or IRIS only. We
assume k1 is the progression rate from latent to active TB with no HIV while k2 is the progression
rate from latent to active TB with HIV, r is the per capita TB treatment rate with no HIV and r1
is the recovery rate by treatment from TB with no HIV. The people successfully treated with TB
return to class of susceptible since TB can reoccur [21]. Let r2 be the per capita HIV treatment
rate with no TB while r3 is the per-capita TB treatment rate in co-infected individuals. We assume
ρ1 and ρ2 to be the transition rates of TB treatment from early phase to late phase and from late
phase to completion phase respectively while η1 and η2 are the rates at which HIV treatment begins
during early phase of TB treatment and late phase of TB treatment respectively. The assumptions
result in the following differential equations that describe the interaction of the two disease model
as:
dS
dt
= Λ− βeS
(TI + C)
N
− dS − λσS
(H +HL + C + C1 + C2)
N
+ r1TT ,
dTL
dt
= βeS
(TI +C)
N
− (d+ k1)TL − λσTL
(H +HL + C + C1 +C2)
N
,
dTI
dt
= k1TL − (d+ dT )TI − λσTI
(H +HL + C + C1 + C2)
N
− rTI ,
dH
dt
= λσS
(H +HL + C +C1 + C2)
N
− r2H − (d+ dH)H − βeH
(TI + C)
N
+ ρ2C2,
dHL
dt
= λσTL
(H +HL + C + C1 + C2)
N
+ βeH
(TI + C)
N
− (k2 + d+ dH)HL,
dC
dt
= k2HL + λσTI
(H +HL +C + C1 + C2)
N
− (d+ dT + dH)C − r3C, (2.3)
dC1
dt
= r3C − ρ1C1 − (d+ dH)C1 − η1C1,
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dC2
dt
= ρ1C1 − ρ2C2 − (d+ dH)C2 − η2C2,
dCT1
dt
= η1C1 − ρ1C
T
1 − (d+ dH + γd
T
H)C
T
1 ,
dCT2
dt
= η2C2 + ρ1C
T
1 − (d+ dH + αd
T
H)C
T
2 ,
dHT
dt
= ρ2C
T
2 + r2H − (d+ dH)H
T ,
dTT
dt
= rTI − r1TT − (d+ dT )TT .
The model flow diagram is shown in figure 1. The solid arrows show the flow within the system
while dashed arrows show flow out from the system. The non-negative initial conditions are chosen.
2.1. Positivity and boundedness of solutions. Since the system deals with human population
which can not be negative, we need to show that all the variables are always non-negative as well as
the solutions of system (2.3) remain positive always with positive initial conditions in the bounded
region defined by
D =
{
(S, TL, TI ,H,HL, C,C1, C2, C
T
1 , C
T
2 ,H
T , TT ) ∈ R
12
+ : N(t) 6
Λ
d
}
.
The next result is very obvious and follows from direct algebraic and differential calculations.
Theorem 2.1. For the non-negative initial conditions, the solutions S, TL, TI , H, HL, C, C1,
C2, C
T
1 , C
T
2 , H
T , TT of the system (2.3) are positive when t > 0 and the region D is positively
invariant.
3. TB Sub-model
We have the TB sub-model when H = HL = C = C1 = C2 = C
T
1 = C
T
2 = H
T = 0, which is
given by:
dS
dt
= f1 = Λ−
βeS
N
TI − dS + r1TT ,
dTL
dt
= f2 =
βeS
N
TI − dTL − k1TL,
dTI
dt
= f3 = k1TL − (d+ dT )TI − rTI ,
dTT
dt
= f4 = rTI − r1TT − dTT − dTTT
(3.1)
with non-negative initial conditions and λT =
βeTI
N
is the force of infection. The total population
is given by
N(t) = S(t) + TL(t) + TI(t) + TT (t).
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Considering biological constraints, the system (3.1) will be studied in the following region:
D1 =
{
(S, TL, TI , TT ) ∈ R
4
+ : N(t) 6
Λ
d
}
.
It can be easily shown that the solutions S, TL, TI , TT of the system are bounded and positively
invariant in D1.
3.1. Disease free equilibrium and stability analysis. The disease free equilibrium is given by
ET0 = (S0, TL0 , TI0 , TT0) =
(
Λ
d
, 0, 0, 0
)
.
The basic reproduction number is defined as the average number of new cases of an infection
caused by one typical infected individual in a population consisting of susceptibles only [7, 8, 11].
Here reproduction number, RT0 , is defined as the number of TB infections produced by an active
TB case. We use the next generation matrix method to find basic reproduction number and the
basic reproduction number is given by
R
T
0 =
βek1Λ
Nd(d2 + dr + ddT + dk1 + rk1 + dTk1)
. (3.2)
We now discuss the stability of disease free equilibrium.
Theorem 3.1. The disease-free equilibrium, ET0 is locally asymptotically stable when R
T
0 < 1 and
unstable when RT0 > 1.
Proof. The Jacobian matrix of the system (3.1) at ET0 is given by
J(ET0 ) =


−d 0 −βeΛ
Nd
r1
0 −d− k1
βeΛ
Nd
0
0 k1 −(d+ dT + r) 0
0 0 r −(r1 + d+ dT )

 . (3.3)
The characteristic polynomial is given by
(x+d)(x+d+dT+r1)
(
x2 + (2d+ r + dT + k1)x+ (d
2 + dr + ddT + dk1 + rk1 + dTk1)−
eβΛk1
Nd
)
.
(3.4)
The first two factors are linear and give eigenvalues −d and −(d + dT + r1) for (3.4), which have
negative real parts. For the remaining quadratic factor we use Routh-Hurwitz stability criterion
by which all the coefficient of quadratic polynomial are positive if RT0 < 1. Hence, E
T
0 is locally
asymptotically stable for RT0 < 1 [16]. 
We now list two conditions that are sufficient to guarantee the global stability of the disease free
equilibrium point. Following Castillo-Chavez et al. [4], we rewrite the model system (3.1) as
dS
dt
= F (S, I),
dI
dt
= G(S, I),
G(S, 0) = 0, (3.5)
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where S ∈ R2 denotes the number of uninfected individuals and I ∈ R2 denotes the number
of infected individuals. E0 = (X
∗, 0) denotes the disease free equilibrium of system (3.5). The
conditions (H1) and (H2) below must be satisfied to guarantee a local asymptotic stability.
(H1) For dS
dt
= F (S, 0), S∗ is globally asymptotically stable,
(H2) G(S, I) = AI− Gˆ(S, I), Gˆ(S, I) ≥ 0 for (S, I) ∈ G2,
where A = DIG(S
∗, 0) is an M-matrix (the off diagonal elements are non negative) and G is the
region where the model makes biological sense. If the system (3.1) satisfies the above two conditions,
then the theorem holds.
Theorem 3.2. The fixed point ET0 = (S
∗, 0) is a globally asymptotically stable equilibrium of
system (3.1) if RT0 < 1 and the assumptions in (3.5) are satisfied.
Proof. We have already proved in theorem (3.1) that for RT0 < 1, E
T
0 is locally asymptotically
stable. Consider
dS
dt
= Λ−
βeS
N
TI − dS + r1TT = F (S, I),
dI
dt
= G(S, I), (3.6)
where G(S, I) =


βeSTI
N
− dTL − k1TL
k1TL − (d+ dT )TI − rTI
rTI − r1TT − dTT − dTTT

 and F (S, 0) =
[
Λ− dS
0
]
.
Since dS/dt = F (S, 0) is a linear equation, S∗ is globally stable. Hence, (H1) holds.
G(S, I) = AI − Gˆ(S, I) and A =

−d− k1 βe 0k1 −d− dT − r 0
0 r −r1 − d− dT

 .
We get,
Gˆ(S, I) =

Gˆ1(S, I)Gˆ2(S, I)
Gˆ3(S, I)

 =

βeTI(1−
S
N
)
0
0

 .
Since S is always less than or equal to N, S
N
≤ 1 and Gˆ1(S, I) > 1. Thus, Gˆ(S, I) ≥ 0 and this
implies that ET0 is globally asymptotically stable. 
3.2. Existence and Stability analysis for endemic equilibrium point. To find conditions
for the existence of an equilibrium for which TB is endemic in the population, denoted by ET1 =
(Sˆ, TˆL, TˆI , TˆT ), the equations in (3.1) are solved in terms of force of infection at steady state λ
∗
T ,
given by
λ∗T =
βeTI
N
. (3.7)
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The system (3.1) reduces to the following:

−(λ∗T + d) 0 0 r1
λ∗T −(d+ k1) 0 0
0 k1 −d− dT − r 0
0 0 r −(r1 + d+ dT )




S
TL
TI
TT

 =


−Λ
0
0
0

 .
Solving this, we get
Sˆ =
Λ(d+ r + dT )(d+ k1)(d+ dT + r1)
A
,
TˆL =
Λ(λ∗T (d+ r + dT ))(d+ dT + r1)
A
,
TˆI =
Λλ∗Tk1(d+ dT + r1)
A
,
TˆT =
rΛλ∗Tk1
A
,
(3.8)
where A = (d+ r + dT )(d+ λ
∗
T )(d + k1)(d+ dT + r1)− rλ
∗
Tk1r1. Using (3.8) in (3.7), we get
λ∗T =
βeΛk1λ
∗
T (d+ dT + r1)
N(d+ r + dT )(d+ λ∗T )(d + k1)(d+ dT + r1)− rλ
∗
Tk1r1
,
which reduces to
λ∗T
[
βeΛk1(d+r1+dT )
N
− (d+ r + dT )(d + λ
∗
T )(d+ k1)(d+ dT + r1) + rλ
∗
Tk1r1
]
(d+ r + dT )(d+ λ∗T )(d+ k1)(d+ dT + r1)− rλ
∗
Tk1r1
= 0,
where λ∗T = 0 corresponds to the disease free equilibrium and
λ∗T =
βeΛk1(d+dT+r1)
N
− d(d+ r + dT )(d+ k1)(d+ dT + r1)
(d+ dT + r)(d+ k1)(d+ dT + r1)− rk1r1
, (3.9)
corresponds to the existence of endemic equilibrium. For a disease to spread, the force of infection
(λ∗T ) should be positive. It can be seen clearly that denominator of (3.9) is always positive. So for
λ∗T to be positive, its numerator should be positive. Therefore,
βeΛk1
N
− d(d+ r + dT )(d+ k1)(d+ dT + r1) > 0,
βeΛk1
Nd(d+ r + dT )(d+ k1)
> 1,
⇒RT0 > 1. (3.10)
Thus, (3.9) reduces to RT0 > 1. We have just proved the following result.
Theorem 3.3. The submodel system (3.1) has a unique endemic equilibrium whenever RT0 > 1.
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3.3. Local stability of endemic equilibrium. We prove the local asymptotic stability of the
endemic equilibrium ET1 , using the center manifold theory, as described in [5, Theorem 4.1], with
ET1 = (Sˆ, TˆL, TˆI , TˆT ) and each of its components as given in (3.7). Firstly we simplify the system
(3.1) to apply this method. Let S = x1, TL = x2, TI = x3 and TT = x4, so that N = x1+x2+x3+x4,
then the system can be written in the form dX
dt
= (f1, f2, f3, f4)
T . The basic reproduction number
of the system (3.1) is given by (3.2). We choose a bifurcation parameter β∗, by solving for βe from
R
T
0 = 1:
β∗ =
Nd(d+ r + dT )(d+ k1)
Λk1
.
The system (3.1) has a disease free equilibrium given by
ET0 = (x10 , x20 , x30 , x40) =
(
Λ
d
, 0, 0, 0
)
.
The Jacobian matrix of the linearized system of (3.11) evaluated at ET0 , J(E
T
0 ) is given as in (3.3).
J(ET0 )|β∗ has a zero eigenvalue which is simple and all the other eigenvalues have negative real
parts, therefore the center manifold theory can be applied.
The Jacobian matrix J(ET0 )|β∗ has a right eigenvector, associated with zero eigenvalue which is
given by w = (w1, w2, w3, w4)
T , where
w1 =
r1
d
−
(d+ r + dT )(d+ k1)(d+ dT + r1)
drk1
,
w2 =
(d+ r + dT )(d + dT + r1)
rk1
,
w3 =
(d+ dT + r1)
r
,
w4 = 1.
(3.11)
Since x10 > 0, there is no restriction on sign of w1 [refer [5], Remark 1, pg. 375], while wi > 0 ∀ i 6= 1.
Further, J(ET0 )|β∗ has a left eigenvector v = (v1, v2, v3, v4), associated with the zero eigenvalue,
where
v1 = 0,
v2 =
k1
(d+ k1)
,
v3 = 1,
v4 = 0.
(3.12)
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The local stability near the bifurcation point β∗ = βe is determined by the signs of the two
associated constants, denoted by a and b which are defined by
a =
4∑
k,i,j=1
vkwiwj
∂2fk
∂xi∂xj
(0, 0),
b =
4∑
k,i,j=1
vkwi
∂2fk
∂xi∂φ
(0, 0),
(3.13)
with φ = βe− β∗ and for βe = β∗, φ = 0.
For the system (3.1), the associated non-zero partial derivatives at ET0 are
∂2f2
∂x2∂x3
=−
β∗d
Λ
,
∂2f2
∂x3∂x4
=−
β∗d
Λ
,
∂2f2
∂x23
=− 2
β∗d
Λ
,
∂2f2
∂x3∂β∗
=1.
From the above expressions, we get
a =−
(d+ dT + r)
2(d+ r + dT )
2d
Λ2rk1
−
2Nd2(d+ dT + r1)
2(d+ r + dT )
r2Λ2
−
Nd2(d+ dT + r1)(d+ dT + r)
rΛ2
,
b =
k1(d+ dT + r1)
r(d+ k1)
.
(3.14)
Since all the terms in the expressions in (3.15) are positive, therefore a < 0 and b > 0. Thus, [5,
Theorem 4.1] implies that the unique equilibrium point of system (3.1), which exists when RT0 > 1
is locally asymptotically stable when β∗ < βe with βe close to β∗ and the system undergoes
transcritical bifurcation at β∗ = βe which is supercritical or forward. Hence, the following result is
established.
Theorem 3.4. The endemic equilibrium ET1 is locally asymptotically stable for the basic reproduc-
tion number RT0 > 1 and the system undergoes supercritical transcritical bifurcation at R0 = 1 and
β∗ = βe acts as the bifurcation parameter.
4. HIV Submodel
We have HIV submodel when TL = TI = TT = C = C1 = C2 = C
T
1 = C
T
2 = 0, which is given by
the following system of equations:
dS
dt
=Λ− dS −
λσSH
N
,
dH
dt
=
λσSH
N
− r2H − (d+ dH)H,
dHT
dt
=r2H − (d+ dH)H
T ,
(4.1)
12 S. KUMAR AND S. JAIN
with non-negative initial conditions and the force of infection is given by
λH =
λσH
N
,
and the total population for the system is N = S + H + HT . Due to biological constraints, the
system (4.1) is studied in the following region
D2 =
{
(S, H, HT ) ∈ R3+ : N(t) 6
Λ
d
}
.
This is easy to prove that the solutions S, H and HT of the system (4.1) are bounded and positively
invariant in D2.
4.1. Disease free equilibrium and stability analysis. The disease free equilibrium for the
system (4.1) is given by
EH0 = (S0, H0, H
T
0 ) =
(
Λ
d
, 0, 0, 0
)
,
and the basic reproduction number is given by
R
H
0 =
Λλσ
Nd(r2 + d+ dH)
. (4.2)
Next we discuss the stability of disease free equilibrium.
Theorem 4.1. The disease free equilibrium, EH0 is locally asymptotically stable when R
H
0 < 1 and
unstable when RH0 > 1.
Proof. The Jacobian matrix of the system (4.1) at EH0 is given by
J(EH0 ) =

−d −
Λλσ
Nd
0
0 Λλσ
Nd
− (r2 + d+ dH) 0
0 r2 −(d+ dH)

 , (4.3)
which has characteristic polynomial
(d+ x)(x+ d+ dH)
(
Λλσ
Nd
− x− d− dH − r2
)
. (4.4)
Eigenvalues for (4.3) are −d,−(d+ dH) and (
Λλσ
Nd
− (d + dH + r2)) which have negative real parts
when Λλσ
Nd(d+dH+r2)
< 1 i.e. RH0 < 1. Thus, E
H
0 is locally asymptotically stable for R
H
0 < 1 and
unstable for RH0 > 1. 
We now discuss the global stability of disease free equilibrium EH0 .
Theorem 4.2. The fixed point EH0 = (S
∗, 0) is a globally asymptotically stable equilibrium of
system (4.1) provided that RH0 < 1 and the assumptions in (3.5) are satisfied.
Proof. Proof is similar to the theorem 3.2 and hence omitted. 
ASSESSING THE EFFECTS OF TREATMENT IN HIV-TB CO-INFECTION MODEL 13
4.2. Existence and Stability of Endemic Equilibrium point. The endemic equilibrium is
given by
EH1 = (S˜, H˜, H˜
T ),
where
S˜ =
N(r2 + d+ dH)
λσ
,
H˜ =
Λ
(r2 + d+ dH)
−
dN
λσ
,
H˜T =
r2
(r2 + d+ dH)
(
Λ
(r2 + d+ dH)
−
dN
λσ
)
.
(4.5)
The HIV endemic exists when λ∗H , given by
λ∗H =
λσHˆ
N
, (4.6)
is positive. Using (4.6) in (4.7), if λ∗H > 0, then
λσ
N
(
Λ
(r2 + d+ dH)
−
dN
λσ
)
> 0,
λσ
(r2 + d+ dH)
>
Nd
Λ
,
Therefore, RH0 > 1. Thus, the endemic equilibrium exists when R
H
0 > 1. We have just proved the
following result.
Theorem 4.3. The endemic equilibrium, EH1 exists whenever R
H
0 > 1.
We now discuss the stability of the endemic equilibrium point EH1 .
Theorem 4.4. The endemic equilibrium EH1 is locally asymptotically stable for the basic reproduc-
tion number RH0 > 1.
Proof. The Jacobian matrix of the system (4.1) at EH1 is given by

Λλσ
N(r2+d+dH )
−(r2 + d+ dH) 0
Λλσ
N(r2+d+dH )
− d 0 0
0 r2 −(d+ dH)

 . (4.7)
The characteristic equation for (4.8) is given by
(x+ d+ dH)
(
x2 +
λσx
N(d+ dH + r2)
− d(r2 + d+ dH) +
Λλσ
N
)
= 0. (4.8)
The factor (x+ d+ dH) gives an eigenvalue −d− dH , which has negative real part. For the other
quadratic factor we use Routh Hurwitz criterion of stability, by which all the coefficients in the
quadratic factor should be positive when RH0 > 1. Therefore, in D2 whenever R
H
0 > 1, E
H
1 is locally
asymptotically stable. 
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5. Analysis of the main model
In this section, we analyze the main model (2.3). Biologically, the full model can have four
equilibria, namely, disease free equilibrium E0, TB only endemic equilibrium E
T , HIV only endemic
equilibrium EH and the interior endemic equilibrium point ETH .
5.1. The disease free equilibrium and stability analysis. The disease free equilibrium is given
by
E0 =
(
Λ
d
, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0
)
.
First, we calculate the basic reproduction number by next generation operator method as in sub-
section (3.1). The transition matrix T and the transmission matrix Σ, are as follows:
T =


0 βeΛ
Nd
0 0 βeΛ
Nd
0 0
0 0 0 0 0 0 0
0 0 Λλσ
Nd
Λλσ
Nd
Λλσ
Nd
Λλσ
Nd
Λλσ
Nd
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0


, (5.1)
Σ =


−d− k1 0 0 0 0 0 0
k1 −d− dT − r 0 0 0 0 0
0 0 −r2 − d− dH 0 0 0 ρ2
0 0 0 k2 − d− dH 0 0 0
0 0 0 k2 C1 0 0
0 0 0 0 r3 C2 0
0 0 0 0 0 ρ1 C3


, (5.2)
where
C1 = −d− dT − dH − r3,
C2 = −d− dH − ρ1 − η1,
C3 = −d− dH − ρ2 − η2.
The dominant eigenvalues of −TΣ−1 are
R
T
0 =
βeΛk1
Nd(d2 + dr + ddT + dk1 + rk1 + dT k1)
=
βeΛk1
Nd(d+ r + dT )(d+ k1)
,
R
H
0 =
Λλσ
Nd(r2 + d+ dH)
.
Thus, the basic reproduction number of the model (2.3) is given by
R0 = max{R
T
0 ,R
H
0 }. (5.3)
Theorem 5.1. The disease free equilibrium, E0 is locally asymptotically stable when R0 < 1 and
unstable when R0 > 1.
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Proof. The Jacobian matrix J(E0) of the model system (2.3) at E0 is given by

−d 0 −βeΛ
Nd
−Λλσ
Nd
−Λλσ
Nd
−Λ(βe+λσ)
Nd
−Λλσ
Nd
−Λλσ
Nd
0 0 0 r1
0 −d− k1
βeΛ
Nd
0 0 0 0 0 0 0 0 0
0 k1 C0 0 0 0 0 0 0 0 0 0
0 0 0 C1
Λλσ
Nd
Λλσ
Nd
Λλσ
Nd
C2 0 0 0 0
0 0 0 0 C3 0 0 0 0 0 0 0
0 0 0 0 k2 C4 0 0 0 0 0 0
0 0 0 0 0 r3 C5 0 0 0 0 0
0 0 0 0 0 0 ρ1 C6 0 0 0 0
0 0 0 0 0 0 η1 0 C7 0 0 0
0 0 0 0 0 0 0 η2 ρ1 C8 0 0
0 0 0 0 0 0 0 0 0 ρ2 −d− dH 0
0 0 r 0 0 0 0 0 0 0 0 −d− dT


(5.4)
where,
C0 = −(d+ r + dT ),
C1 =
Λλσ
Nd
− (d+ dH + r2),
C2 =
Λλσ
Nd
+ ρ2,
C3 = −(d+ dH + k2),
C4 = −(d+ dH + dT + r3),
C5 = −(d+ dH + η1 + ρ1),
C6 = −(d+ dH + η2 + ρ2),
C7 = −(d+ dH + γd
T
H + ρ1),
C8 = −(d+ dH + αd
T
H + ρ2).
The characteristic equation of (5.4) is given by the following:
(x+ d+ dH + k2)(x+ d+ dT + r1)(x+ d+ dT + dH + r3)(x+ d+ dH + γd
T
H + ρ1)
(x+ d)(x + d+ dH)(x+ d+ dH + ρ1 + η1)(x+ d+ dH + αd
T
H + ρ2)(x+ d+ dH + ρ2 + η2)(
x+ d+ dH + r2 −
Λλσ
Nd
)(
x2 + (2d + r + dT + k1)x+ d
2 + dr + ddT + dk1 + rk1
+ dTk1 −
βeΛk1
Nd
)
= 0.
(5.5)
Clearly, the first nine factors in (5.5) give eigenvalues with negative real parts. Eigenvalue of last
two factors would have negative real parts if RH0 < 1 and R
T
0 < 1 respectively by using Routh-
Hurwitz Stability criterion.
Since all the coefficients of the quadratic factors are positive, by Routh-Hurwitz criterion the disease
free equilibrium is locally asymptotically stable for R0 < 1 and unstable for R0 > 1. 
5.2. The endemic equilibria and their stability. In this section, we discuss the various endemic
equilibria and their stability. Biologically, there can be three endemic equilibria that are TB
endemic, HIV endemic and an equilibrium point where both the diseases are endemic.
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5.2.1. TB endemic equilibrium and stability. The TB endemic is given by
ET = (Sˆ, TˆL, TˆI , 0, 0, 0, 0, 0, 0, 0, 0, TˆT ).
One condition for existence of TB endemic equilibrium can be shown as in (3.2) because for TB to
be endemic λ∗T > 0 which is given by (3.9) and results in R
T
0 > 1 and the second condition will be
proved by using center manifold theory. The Sˆ, TˆL, TˆI and TˆT are given as in (3.8).
We prove the local stability of the endemic equilibrium ET , using the center manifold theory, as
described in [5, Theorem 4.1]. We simplify the system (2.3) to apply this method. Let S = x1, TL =
x2, TI = x3, H = x4, HL = x5, C = x6, C1 = x7, C2 = x8, C
T
1 = x9, C
T
2 = x10, H
T = x11 and
TT = x12, so that N = x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 + x11 + x12. The model
system (2.3) can be written in the form dX
dt
= (f1, f2, f3, f4, f5, f6, f7, f8, f9, f10, f11, f12)
T
maintaining the sequence.
The basic reproduction number of the system (2.3) is given by 5.3. Now, we choose a bifurcation
parameter β∗, by solving for RT0 = 1, we get,
β∗ =
Nd(d+ r + dT )(d+ k1)
Λk1
.
The Jacobian matrix of the linearized system of (5.7) evaluated at disease free equilibrium point
E0 of system (2.3) denoted by J(E0) and evaluated at β
∗, that is, J(E0)|β∗ has a zero eigenvalue
which is simple and all other eigenvalues have negative real parts when RH0 < 1. Therefore, we can
apply center manifold theory here.
The Jacobian matrix J(E0)|β∗ has a right eigenvector, associated with zero eigenvalue given by
w = (w1, w2, w3, w4, w5, w6, w7, w8, w9, w10, w11, w12)
T , where wi = 0 for all i except
i = 1, 2, 3 and 12 which are as follows:
w1 =
r1
d
−
(d+ r + dT )(d+ k1)(d+ dT + r1)
drk1
,
w2 =
(d+ r + dT )(d + dT + r1)
rk1
,
w3 =
(d+ dT + r1)
r
,
w12 =1.
(5.6)
The J(E0)|β∗ has a left eigenvector v = (v1, v2, v3, v4, v5, v6, v7, v8, v9, v10, v11, v12) associated
with the zero eigenvalue, where
vi = 0 ∀ i 6= 2, 3,
v2 =
k1
(d+ k1)
,
v3 = 1.
(5.7)
For determining the local stability near the bifurcation point β∗ = βe, we need to determine
the signs of the two associated constants, a and b, defined by (3.13) with φ = βe − β∗ and for
βe = β∗, φ = 0.
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Hence, the associated non-zero partial derivatives at E0 are
∂2f2
∂x2∂x3
= −
β∗d
Λ
,
∂2f2
∂x3∂x12
= −
β∗d
Λ
,
∂2f2
∂x23
= −2
β∗d
Λ
,
∂2f2
∂x3∂β∗
= 1.
From the above calculations, we get
a =−
(d+ dT + r)
2(d+ r + dT )
2d
Λ2rk1
−
2Nd2(d+ dT + r1)
2(d+ r + dT )
r2Λ2
−
Nd2(d+ dT + r1)(d+ dT + r)
rΛ2
,
b =
k1(d+ dT + r1)
r(d+ k1)
.
(5.8)
We conclude that a < 0 and b > 0. Thus, our calculations together with [5, Theorem 4.1] implies
that there exists a TB endemic equilibrium point of system (2.3) when RT0 > 1 and R
H
0 < 1 and is
locally asymptotically stable when β∗ < βe with βe close to β∗ and system undergoes supercritical
transcritical bifurcation. Hence, we get the next result.
Theorem 5.2. The endemic equilibrium point ET exists for R
T
0 > 1 and R
H
0 < 1 and is locally
asymptotically stable for RT0 near 1 and system undergoes supercritical transcritical bifurcation at
R
T
0 = 1 whereas β
∗ is the bifurcation parameter.
5.2.2. HIV endemic and its stability. The HIV endemic is given by
EH = (S˜, 0, 0, H˜, H˜L, 0, 0, 0, 0, 0, H˜
T , 0).
One existence condition of HIV endemic equilibrium can be shown as in (4.3) and the other condition
will be proved by using center manifold theory. The S˜, H˜, H˜L and H˜
T are given as in (4.5). Again
we use the center manifold theory, as described in [refer [5, Theorem 4.1]. We choose a bifurcation
parameter λ∗. By solving for RT0 = 1, we get,
λ∗ = λσ =
Nd(d+ dH + r2)
Λ
.
The Jacobian matrix J(E0) evaluated at λ
∗ i.e. J(E0)|λ∗ has a simple zero eigenvalue for R
T
0 < 1.
Hence, center manifold theory can be applied here. Proceeding as in previous theorem we can easily
calculate
a = −
(d+ dH + η2 + ρ2)λσd(d+ dH)
r2Λ(d+ dH + r2 + ρ2)
(
2(d+ dH)
r2
+ 1
)
,
b =
(d+ dH + η2 + ρ2)(d+ dH)
(d+ dH + r2 + ρ2)r2
.
(5.9)
From (5.9), we get a < 0 and b > 0. Thus, from our calculation and [5, Theorem 4.1], there
exists an HIV endemic EH of the model system (2.3), when R
T
0 < 1 and R
H
0 > 1 and is locally
asymptotically stable when λ∗ < λσ with λσ close to λ∗ and supercritical transcritical bifurcation
occurs at λ∗ = λσ. Thus, we get the following result:
18 S. KUMAR AND S. JAIN
Theorem 5.3. The endemic equilibrium point EH exists for R
T
0 < 1 and R
H
0 > 1 which is locally
asymptotically stable for RH0 near 1 and supercritical transcritical bifurcation occurs at R
H
0 = 1 and
λ∗ acts as the bifurcation parameter.
5.2.3. Interior endemic equilibrium. The interior equilibrium point of system (2.3) exists when
both the diseases are present in the population. For both the diseases to be endemic, force of
infection λT and λH should be positive and given by (2.1) and (2.2) respectively. It is given by
EHT = (S`, T`L, T`I , H`, H`L, C`, C`1, C`2, C`
T
1 , C`
T
2 , H`
T , T`T ).
5.2.4. Summary of the equilibrium points. Table 1 summarizes the existence and stability
conditions on the different equilibrium points of the model system (2.3).
Equilibrium Point Existence Conditions Stability
Disease free equilibrium Always exists l.a.s for R0 < 1
TB endemic equilibrium RT0 > 1 and R
H
0 < 1 l.a.s when R
T
0 > 1 and R
H
0 < 1
HIV endemic equilibrium RT0 < 1 and R
H
0 > 1 l.a.s when R
T
0 < 1 and R
H
0 > 1
Interior equilibrium RT0 > 1 and R
H
0 > 1
Table 1. Equilibrium Points and Their Existence and Stability Conditions
6. Numerical results and discussion
In the present section, numerical simulations are carried out using various set of parameters.
The numerical values of the parameters are given in Table 2 and time is set to 50 years. We use
MATLAB for the numerical simulations of the system (2.3).
For the numerical analysis, we use N(0) = 20, 000, S(0) = 12000, TL(0) = 5000, T (I) =
1032, H(0) = 340, HL(0) = 113, C(0) = 114, C1(0) = 64, C2(0) = 64, C
T
1 (0) = 32, C
T
2 (0) =
32, HT (0) = 265, TT (0) = 944 as the initial conditions. For initial conditions, it is assumed
that more than half of the total population belong to the susceptible. One quarter of the total
population is infected with latent TB [25]. The population infected with HIV only is assumed to
be 1.7% and 78% of them get proper treatment [20] and 11% of TB active people get co-infected
with HIV. The remaining values are estimated assuming we are in controlled situation.
The natural death rate d corresponds to the life expectancy of 71.4 years [24] and k2 > k1 implies
that progression of TB is faster in co-infected individuals. It can be seen that β and e always appear
together and βe determines the TB reproduction number RT0 . Similarly, λ and σ always appear
together and the product λσ determines the HIV reproduction number RH0 . In our calculations, we
have fixed η1 = 0.03 and η2 = 0.02 from the given range in Table 2 and for the Figure 4, we variate
the values within range. We choose different values of βe and λσ for our numerical simulations
which are βe = 0.5 for RT0 < 1, βe = 2 for R
T
0 > 1, λσ = 0.3 for R
H
0 < 1 and λσ = 1 for R
H
0 > 1
resulting RT0 = 0.73, R
T
0 = 2.93, R
H
0 = 0.5515 and R
H
0 = 1.84, respectively.
Figure 2 depicts graphical representations of the change in population infected with single disease
only and co-infected under no treatment regime, with change in reproduction number by plotting
TL + TI , H and C versus time. For R
T
0 < 1 and R
H
0 < 1, Figure 2 (A) shows that the diseases die
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Parameter Symbol Estimate Source
Recruitment Rate Λ 280 assumed
Natural death rate d 0.01401 estimated
TB induced death rate dT 0.1 [3, 17]
HIV induced death rate dH 0.2 [17]
IRIS induced death rate dTH 0.33 estimated
Progression rate from latent to active TB with no HIV k1 0.5 [3, 17]
Progression rate from latent to active TB with HIV k2 1.3k1 [19]
Transition rate of TB treatment from early to late phase ρ1 5.56 × 10
−3 [14]
Transition rate of TB treatment from late to completion phase ρ2 1.11 × 10
−2 [14]
Recovery rate from TB with no HIV r1 0.82 estimated
Per capita HIV treatment rate with no TB r2 0.33 [1]
Per capita TB treatment rate in co-infected individuals r3 0.1 [14]
Per-capita TB treatment rate with no HIV r 0.55 [1]
HIV early treatment rate η1 0− 0.05 [14]
HIV late treatment rate η2 0− 0.05 [14]
Rate of occurrence of IRIS γ 1× 10−3 [14]
Table 2. Model Parameters
out with time and approach the disease free equilibrium point E0. This implies that for R0 < 1,
diseases can not persist for longer duration of time. Figure 2 (B) shows that for RT0 < 1 and R
H
0 > 1,
TB infection decreases rapidly with time and finally vanishes, while HIV infected population first
increases rapidly and then decreases before attaining a constant value which is H˜ of equilibrium
point EH . Co-infected population also increases very rapidly even when R
T
0 < 1 and then decreases
to become constant. Figure 2 (C) shows that for RT0 > 1 and R
H
0 < 1, TB infected population
first increases very rapidly and then slowly decreases to a constant value which is TˆL + TˆI , while
HIV infected population vanishes very soon. Thus, the co-infected population also decreases with
time and then vanishes. This corresponds to the equilibrium point ET . Figure 2 (D) shows that
for RT0 > 1 and R
H
0 > 1, both the infections in population first increase to a maximum value and
after that decrease rapidly to attain constant values and these constant values correspond to the
interior equilibrium point EHT . This represents that in favourable conditions, that is, R
T
0 > 1 and
R
H
0 > 1, both the diseases favour each other and continue increasing rapidly and after reaching a
maximum value, they again decrease to attain a constant value. This shows that no epidemic can
last forever. Moreover, co-infected population is also maximum in this case.
Figure 3 shows the effect of reproduction number with early or late initiation of ART during
TB treatment on disease-induced deaths. The disease-induced deaths are the deaths among the
population caused by the diseases other than natural deaths. We have plotted the time versus
disease-induced deaths in compartments CT1 and C
T
2 which is (dH + γd
T
H)C
T
1 + (dH + αd
T
H)C
T
2 .
We have plotted the graphs for four different set of values η1 = 0, η2 = 0; η1 = 0.03, η2 = 0.02
; η1 = 0.04, η2 = 0.02 and η1 = 0.02, η2 = 0.04. Figure 3 shows that higher the rate of early
phase HIV treatment during TB treatment, lesser are the disease-induced deaths. Figure shows
that for R0 < 1 disease-induced deaths decrease with time and vanish after some time. For R
T
0 < 1
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Figure 2. Effect of Reproduction Number on TB only infected population (TL +
TI), HIV only infected population (H) and Co-infected population undergoing no
treatment (C).
and RH0 > 1, the disease-induced deaths decrease to vanish after attaining a maximum value. For
R
T
0 > 1 and R
H
0 < 1 the disease-induced deaths increase after a slight decrease and then keep on
decreasing. For R0 > 1, the disease-induced deaths increase to a maximum value and then decrease
to attain a constant value. Figure 3 shows that higher the rate of HIV early treatment during TB
treatment, lesser are the disease-induced deaths, while increased rate of HIV late treatment does
not have very remarkable impact on disease-induced deaths.
The total number of disease induced deaths in different cases are given in Table 3. Table 3 shows
that for different reproduction numbers the total number of disease-induced deaths are lesser for
higher value of η1 while η2 does not affect it in similar manner.
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Figure 3. Effect of early or late Initiation of ART during TB treatment on disease-
induced deaths of population under Co-treatment
Reproduction number
Deaths when
η1 = 0, η2 = 0
Deaths when
η1 = 0.03, η2 = 0.02
Deaths when
η1 = 0.04, η2 = 0.02
Deaths when
η1 = 0.02, η2 = 0.04
R0 < 1 228 203 196 204
R
T
0 < 1 and R
H
0 > 1 1096 990 954 1023
R
T
0 > 1 and R
H
0 < 1 507 490 465 511
R
T
0 > 1 and R
H
0 > 1 3678 3350 3228 3473
Table 3. Total disease-induced deaths in span of 50 years for different values of η1
and η2
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Figure 4. Effect of single disease infection treatment on the infected population
(TL + TI +H +HL + C + C1 + C2 + C
T
1 + C
T
2 ) and susceptible (S).
Figure 4 shows the effect of treatment for single disease infection, that is, effect of r, r2 and r1 on
susceptible and the total infected population (TL+TI+H+HL+C+C1+C2+C
T
1 +C
T
2 ). We plot
the graph of the time versus susceptible and infected population for different reproduction numbers.
For population without treatment, we assume r = r1 = r2 = 0, that is, there is no treatment for TB
for TI class, so no recovery by treatment i.e. r1 = 0 and there is no treatment for H compartment.
Figure 4 (A) shows that for basic reproduction number R0 < 1, the infection dies out with time
when treatment is considered while for no single disease treatment infected population does not
vanish even in a span of 50 years. The susceptible tend to increase with treatments while for the
other case susceptible decrease to attain a constant value which is very small. Figure 4 (B) shows
that when RT0 < 1 and R
H
0 > 1, for no treatment of single disease infected population, the infected
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Figure 5. Effect of TB only and HIV only treatments individually on the disease-
induced deaths when RT0 > 1 and R
H
0 > 1.
population first increases rapidly and then decreases to become constant at a higher value than with
the treatment. The susceptible population undergoing treatment for single disease infection as well
as co-infection treatment is always greater than the susceptible population with only co-infection
treatment and with passage of time treatment increases the susceptible population while with no
treatment, susceptible population decreases to a very small value. In our discussion henceforth, the
term treatment signifies the treatments for single disease infected population. Figure 4 (C) shows
that for RT0 > 1 and R
H
0 < 1, infected population first increases in both cases and then decreases,
but for no treatment infection increases rapidly than for the treatment and then decreases to attain
a constant value less than the value attained by the curve with treatment. The susceptible in both
cases decrease to attain a constant value but susceptible population without treatment decrease
very rapidly to attain an extremely low value as compared to susceptible with treatment. Figure
4 (D) shows that for RT0 > 1 and R
H
0 > 1, infected population without treatment increases more
rapidly and then decreases to attain a constant value a little larger than for the population with
treatment. The susceptible population decreases rapidly with time so that population without
treatment is always less than the population with treatment.
We conclude that in absence of treatment for single disease infection, the disease-induced deaths
increase and infection persists even when R0 < 1, disease-induced deaths increase independent of
the reproduction number and the susceptible population decreases to a very small quantity.
Figure 5 shows the effect of single disease treatments individually on the disease-induced deaths
when diseases are epidemic where disease-induced deaths are the deaths which are caused due to
diseases. It represents the disease-induced deaths in all the three cases. It can be clearly seen
that the disease-induced deaths are maximum when there is no treatment for TB only infected
individuals while it is lesser in the case of no treatment for HIV infected individuals followed by
the case when both the treatments are given. This figure shows that TB only treatment is most
important to reduce the infection and disease-induced deaths. While the statistics are best when
both the treatments are given to the population. Moreover, this figure also shows that if diseases are
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epidemic then treatment for one disease only, that is, treatment for TB only or HIV only infected
individuals is not sufficient for the eradication of diseases from the population.
7. Conclusion
The main model (2.3) is a 12 dimensional system which focuses on need of single disease treat-
ment in addition to co-infection treatment. The TB only and HIV only models have globally stable
disease free equilibria when their corresponding reproduction number is less than unity. For repro-
duction number greater than unity, the endemic equilibria also exist and are locally asymptotically
stable. The full HIV-TB co-infection model is shown to have a locally asymptotically stable dis-
ease free equilibrium when R0 < 1. The HIV only and TB only equilibrium exist and are locally
asymptotically stable when RH0 > 1, R
T
0 < 1 and R
H
0 < 1, R
T
0 > 1, respectively. Numerical sim-
ulations indicate the presence of interior equilibrium for RH0 > 1, R
T
0 > 1. The system undergoes
supercritical transcritical bifurcation when RT0 = 1 and R
H
0 = 1 whereas β
∗ = βe and λ∗ = λσ act
as the bifurcation parameters respectively.
The simulation results provided many interesting insights into the effect of the dynamics of
HIV-TB co-infection. Figure 2 shows that the presence of TB may have a significant influence
on HIV dynamics. For endemic TB, prevalence of HIV increases. When HIV is endemic that
is RH0 > 1 then even for R
T
0 < 1, the co-infected population increases dramatically. Figure 3
shows that early initiation of ART during TB treatment is more effective to reduce disease-induced
deaths while late initiation doesn’t have very remarkable impact on it. Figure4 shows that co-
infection treatment alone is not sufficient to eradicate the diseases, treatment for TB only and HIV
only patients separately is also necessary. In the absence of that disease-induced deaths become
very high and infection prevails even when reproduction number is less than unity. Numerical
results show that investing more in single disease infection treatments is more effective to reduce
the infection and disease-induced deaths. Figure 5 emphasises the role of TB only treatment in
reducing the infection in population and decreasing the disease-induced deaths when both the
diseases are epidemic. Investing more in the TB treatment programs can be a better approach
to control the disease dynamics as it can be completely cured and its duration is short. Thus,
declining the HIV prevalence. Moreover, TB is more contagious than HIV and a single infection
can cause many secondary infections. Hence, controlling TB infection can be an important aspect
in controlling the co-infection dynamics but treatment for one disease only is not sufficient for the
complete eradication of the diseases from the population.
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